The broad, long-term objective of this proposal is to understand the role of the tissue factor-thrombin-PAR-1 pathway in viral infections. This is an understudied area. Viral infections are detected by various intracellular receptors, including toll-like receptor (TLR) 3. The clotting system is activated during viral infections as part of the host innate immune response. Coagulation proteases, such as thrombin, in the clotting system activated cells by cleavage of PARs, including PAR-1. In humans PAR-1 is the major thrombin receptor on platelets and is the target of the new antiplatelet drug vorapaxar. Mice do not express PAR-1 on their platelets and allow us to investigate the role of PAR-1 in cells other than platelets. We found that the tissue factor-thrombin-PAR-1 pathway protected mice from infection with coxsackievirus B3 (CVB3) and influenza A virus (IAV). We found that PAR-1 activation enhanced TLR3-dependent IFN? expression. A type I interferon response plays a central role in fighting viral infections. The current proposal will extend our exciting discovery and determine the role of PAR-1 in different cell types in CVB3-induced myocarditis and IAV infection of the lung using a variety of transgenic mouse lines. Our proposal has 2 specific aims.
Specific Aim 1 : Determine the role of PAR-1 expressed on different cell types in the host response to CVB3-induced myocarditis. General hypothesis: PAR- 1 contributes to the antiviral response to CVB3 infection of the heart by enhancing IFN? expression and by inhibiting viral replication.
Specific Aim 2 : Determine the role of PAR-1 expressed on different cell types in the host response to influenza A. General hypothesis: PAR-1 expression by EC contributes to the maintenance of vascular integrity and PAR-1 on hematopoietic cells regulates the antiviral response in the lung after IAV infection. Viral infections cause considerable morbidity and mortality worldwide. Our studies are significant because they may elucidate new pathways in the host defense system that are used to combat viral infections.
The project investigates the contribution of the clotting system and PAR-1 activation to the host response to viral infection. We will investigate the role of this pathways in coxsackievirus B3-induced myocarditis and influenza A-induced viral pneumonia. We hope to identify new pathways that protect us from viral infections.
| Antoniak, Silvio; Tatsumi, Kohei; Bode, Michael et al. (2017) Protease-Activated Receptor 1 Enhances Poly I:C Induction of the Antiviral Response in Macrophages and Mice. J Innate Immun 9:181-192 |
| Tatsumi, Kohei; Antoniak, Silvio; Subramaniam, Saravanan et al. (2016) Anticoagulation increases alveolar hemorrhage in mice infected with influenza A. Physiol Rep 4: |
| Antoniak, S; Tatsumi, K; Hisada, Y et al. (2016) Tissue factor deficiency increases alveolar hemorrhage and death in influenza A virus-infected mice. J Thromb Haemost 14:1238-48 |
| Rondina, Matthew T; Tatsumi, Kohei; Bastarache, Julie A et al. (2016) Microvesicle Tissue Factor Activity and Interleukin-8 Levels are Associated with Mortality in Patients with Influenza A/H1N1 Infection. Crit Care Med 44:e574-8 |
| Tatsumi, Kohei; Mackman, Nigel (2015) Tissue Factor and Atherothrombosis. J Atheroscler Thromb 22:543-9 |
| Antoniak, Silvio; Mackman, Nigel (2014) Multiple roles of the coagulation protease cascade during virus infection. Blood 123:2605-13 |
| Owens 3rd, Albert Phillip; Byrnes, James Robert; Mackman, Nigel (2014) Hyperlipidemia, tissue factor, coagulation, and simvastatin. Trends Cardiovasc Med 24:95-8 |
| Mackman, Nigel; Antoniak, Silvio (2014) Roles of PAR1 and PAR2 in viral myocarditis. Thromb Res 133 Suppl 1:S18-20 |
| Antoniak, Silvio; Mackman, Nigel (2014) Coagulation, protease-activated receptors, and viral myocarditis. J Cardiovasc Transl Res 7:203-11 |
| Mackman, Nigel (2014) New targets for atherothrombosis. Arterioscler Thromb Vasc Biol 34:1607-8 |
Showing the most recent 10 out of 12 publications
